Company intelligence
Molecular Partners
Pioneering DARPin Therapeutics for Patients
Biotechnology Research
Schlieren-Zürich, CH
142 employees
Founded 2004
1 public signals
About Molecular Partners
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA.
Verified activity
Signals from Molecular Partners
1 published signal